Paper20165580
Can alternative medicine do better than placebo?: Does it even matter?
Moyad MA. Can Urol Assoc J, 2010. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Can alternative medicine do better than placebo?: Does it even matter? Papers, record 20165580. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20165580
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15656714 | Monograph. Angelica sinensis. | Altern Med Rev | 2004 | https://conductscience.org/library/papers/15656714 | PubMed |
| 2 | 19025432 | Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer. | Pharmacotherapy | 2008 | https://conductscience.org/library/papers/19025432 | PubMed |
| 3 | 16323982 | Antiandrogenic therapy can cause coronary arterial disease. | Int J Urol | 2005 | https://conductscience.org/library/papers/16323982 | PubMed |
| 4 | 19731578 | Comparison of objective and patient-reported hot flash measures in men with prostate cancer. | J Support Oncol | 2009 | https://conductscience.org/library/papers/19731578 | PubMed |
| 5 | 16278617 | Use of dong quai (Angelica sinensis) to treat peri- or postmenopausal symptoms in women with breast cancer: is it appropriate? | Menopause | 2005 | https://conductscience.org/library/papers/16278617 | PubMed |
| 6 | 19064574 | Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. | Cancer Epidemiol Biomarkers Prev | 2008 | https://conductscience.org/library/papers/19064574 | PubMed |
| 7 | 15885584 | Promoting general health during androgen deprivation therapy (ADT): a rapid 10-step review for your patients. | Urol Oncol | 2005 | https://conductscience.org/library/papers/15885584 | PubMed |
| 8 | 17179056 | Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. | Ann Intern Med | 2006 | https://conductscience.org/library/papers/17179056 | PubMed |
| 9 | 12109340 | The placebo effect and randomized trials: analysis of conventional medicine. | Urol Clin North Am | 2002 | https://conductscience.org/library/papers/12109340 | PubMed |
| 10 | 16006929 | Parenteral medroxyprogesterone for the management of luteinizing hormone releasing hormone induced hot flashes in men with advanced prostate cancer. | J Urol | 2005 | https://conductscience.org/library/papers/16006929 | PubMed |
| 11 | 19129205 | A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). | Ann Oncol | 2009 | https://conductscience.org/library/papers/19129205 | PubMed |
| 12 | 19963436 | Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. | Lancet Oncol | 2010 | https://conductscience.org/library/papers/19963436 | PubMed |
| 13 | 17593379 | Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. | Arch Gynecol Obstet | 2007 | https://conductscience.org/library/papers/17593379 | PubMed |
| 14 | 9418683 | Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. | Fertil Steril | 1997 | https://conductscience.org/library/papers/9418683 | PubMed |
| 15 | 16139656 | Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. | Lancet | 2005 | https://conductscience.org/library/papers/16139656 | PubMed |
| 16 | 19515737 | Meta-analysis of the effects of flaxseed interventions on blood lipids. | Am J Clin Nutr | 2009 | https://conductscience.org/library/papers/19515737 | PubMed |
| 17 | 17472816 | Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. | Clin Ther | 2007 | https://conductscience.org/library/papers/17472816 | PubMed |
| 18 | 20165579 | Dong Quai (angelica sinensis) in the treatment of hot flashes for men on androgen deprivation therapy: results of a randomized double-blind placebo controlled trial. | Can Urol Assoc J | 2010 | https://conductscience.org/library/papers/20165579 | PubMed |
| 19 | 11937433 | Complementary/alternative therapies for reducing hot flashes in prostate cancer patients: reevaluating the existing indirect data from studies of breast cancer and postmenopausal women. | Urology | 2002 | https://conductscience.org/library/papers/11937433 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20165580
GET https://conductscience.org/api/papers/v1/20165580/authors